Trial Profile
A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 19 Nov 2020
Price :
$35
*
At a glance
- Drugs DHACM (Primary)
- Indications Plantar fasciitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors MiMedx
- 26 Jun 2019 Status changed from active, no longer recruiting to completed.
- 28 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 24 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2018.